Re: AHA late breaking abstract
in response to
by
posted on
Nov 11, 2019 10:50AM
"Has RVX applied a patent to protect this discovery in relation to ABET in the targeted patient population?"
An alkaline phosphatase related patent could be the one DM was referring to in the webcast.
BDAZ